Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Glup montecchio dynamic testing in sui & pelvic prolapse_vignoli

775 views

Published on

Glup Montecchio 24-9-10

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Glup montecchio dynamic testing in sui & pelvic prolapse_vignoli

  1. 1. Dynamic testing in SUI & Pelvic Prolapse
  2. 3. Urodynamics : which test and when? <ul><li>In recent years the role of urodynamics in the assessment of stress urinary incontinence (SUI) has become contentious. </li></ul><ul><li>Proponents and Opponents </li></ul><ul><li>Result : the literature is contradictory and lacks adequate evidence, rendering meaningful conclusions difficult. </li></ul>
  3. 4. Cons: The NICE document <ul><li>The Guideline states : </li></ul><ul><li>Pre-op UDS are NOT necessary for women with “ pure symptoms of SUI “ </li></ul><ul><li>The management of Urinary incontinence in women.NICE Clinical Guideline 40 ,2006 </li></ul>
  4. 5. Pro: Agur et a , 2009
  5. 6. Agur et a , 2009
  6. 7. Cons: Limited effect of UDS on decision-making and outcome <ul><li>Pro : Griffiths D , ICI Report on Dynamic Testing , 2005 </li></ul><ul><li>All patients in any symptom group ( i.e, SUI ) have similar underlying pathophysiology requiring similar treatment , and so UDS cannot classify them any better than symptoms alone </li></ul><ul><li>Current treatments are so non-specific that underlying dysfunction is unimportant : treatment works equally well or poorly in any case </li></ul>
  7. 8. Pro : Digesu et a.,2009
  8. 9. Risk factors in SUI & Prolapse surgery <ul><li>Detrusor dysfunction ( including de novo urgency) </li></ul><ul><li>ISD vs Hypofunctional urethra </li></ul><ul><li>Emptying problems </li></ul>
  9. 10. Detrusor dysfunction ( including de novo urgency )
  10. 11. Pro: Flisser A & Blaivas J , J.Urol , 2003 Urgency : the spectrum of urodynamics
  11. 12. Cons : G. Hosker - Committee 6 -Dynamic testing ICI ,2008
  12. 15. Urethral function studies VLPP - MUCP
  13. 16. Artibani W , Point - Counterpoint , AUA 2010
  14. 31. Emptying problems
  15. 32. <ul><li>Cons : </li></ul>
  16. 33. Emptying problems The Fact Sheet <ul><li>Pro: </li></ul><ul><li>Almost half of all women with advanced POP experienced incomplete bladder emptying </li></ul><ul><li>Dain L,Auslander R,Rosen T et a.Urodynamic findings in women with pelvic organ prolapse and obstructive voiding symptoms.Int J Gynaecol Obstet , 2010 </li></ul><ul><li>Recent evidence suggests that 35.5% of women with SUI have a PVR greater than 50 ml and 15.9% have a PVR greater than 100 ml . </li></ul><ul><li>Tseng LH, Liang CC, Chang YL,  et al . Postvoid residual urine in women with stress incontinence. Neurourol Urodyn 2008; 27:48–51 . </li></ul><ul><li>Approx. 25% of patients with SUI show detrusor underactivity or acontractile detrusor accounting for 36% failure rate after mid-urethral sling placement. </li></ul><ul><li>Kuo HC. Effect of detrusor function on the therapeutic outcome of sub-urethral sling procedure using a polypropilene sling for stress urinary incontinence in women.Scand J Urol Nephrol 2007;41:138-43 </li></ul><ul><li>Cons: </li></ul><ul><li>The satisfaction rate was 98.1% in patients with normal detrusor function, 82% in patients with detrusor underactivity or an acontractile detrusor and 75% in patients with detrusor overactivity (p<0.05). </li></ul>
  17. 34. Cons : Conclusions
  18. 35. Pro : Conclusions 1 <ul><li>SUI has a complex multifactorial mechanism which at present is poorly understood </li></ul><ul><li>Urodynamic evaluation may be rather primitive and questionable </li></ul><ul><li>BUT </li></ul><ul><li>Today we have nothing better </li></ul>
  19. 36. Pro: Conclusions 2 <ul><li>Any urodynamic parameter must be correctly interpreted </li></ul><ul><li>Any incongruence with the clinical picture should act as a red flag and imply a more detailed evaluation </li></ul><ul><li>Risk stratification is the basis of rational treatment recommendations in the context of scientific available evidence </li></ul>

×